FDA official logo
GSRS logo
PFDA official logo

OBINUTUZUMAB

  • UNII: O43472U9X8
  • Preferred Substance Name: OBINUTUZUMAB

  • 949142-50-1
  • AFUTUZUMAB
  • GA101
  • GA-101
  • GAZYVA
  • GAZYVARO
  • HUMAB<CD20>
  • HUMABCD20
  • IMMUNOGLOBULIN G1, ANTI-(HUMAN CD20 (ANTIGEN)) (HUMAN-MOUSE MONOCLONAL GA101 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL GA101 .KAPPA.-CHAIN, DIMER
  • IMMUNOGLOBULIN G1, ANTI-(HUMAN CD20 (ANTIGEN)) (HUMAN-MOUSE MONOCLONAL GA101 HEAVY CHAIN), DISULPHIDE WITH HUMAN-MOUSE MONOCLONAL GA101 .KAPPA.-CHAIN, DIMER
  • OBINUTUZUMAB [INN]
  • OBINUTUZUMAB [JAN]
  • OBINUTUZUMAB [MART.]
  • OBINUTUZUMAB [MI]
  • OBINUTUZUMAB [PURPLE BOOK, CDER]
  • OBINUTUZUMAB [USAN]
  • OBINUTUZUMAB [VANDF]
  • OBINUTUZUMAB [WHO-DD]
  • RG-7159
  • RO 5072759
  • RO5072759
  • RO-5072759
  • RO-5072759 HUMAB<CD20>

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.